Safety and tolerability of SARS‐Cov‐2 vaccination in patients with myasthenia gravis: A multicenter experience

por Farina, Antonio, Falso, Silvia, Cornacchini, Sara, Spagni, Gregorio, Monte, Gabriele, Mariottini, Alice, Massacesi, Luca, Barilaro, Alessandro, Evoli, Amelia, Damato, Valentina
Publicado 2022

Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis

por Spagni, Gregorio, Gastaldi, Matteo, Businaro, Pietro, Chemkhi, Zeineb, Carrozza, Cinzia, Mascagna, Giovanni, Falso, Silvia, Scaranzin, Silvia, Franciotta, Diego, Evoli, Amelia, Damato, Valentina
Publicado 2022

New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report

por Bianco, Assunta, Colò, Francesca, Falso, Silvia, Russo, Rosellina, Carlà, Matteo Maria, Minucci, Angelo, Cadoni, Gabriella, Lucchini, Matteo, Cicia, Alessandra, Calabresi, Paolo, Mirabella, Massimiliano
Publicado 2022

Immunological response after SARS-CoV-2 infection and mRNA vaccines in patients with myasthenia gravis treated with Rituximab

por Damato, Valentina, Spagni, Gregorio, Monte, Gabriele, Scandiffio, Letizia, Cavalcante, Paola, Zampetti, Nicole, Fossati, Marco, Falso, Silvia, Mantegazza, Renato, Battaglia, Alessandra, Fattorossi, Andrea, Evoli, Amelia
Publicado 2023